Nyowani COVID-19 Mushonga Wemuromo Unoratidza 100% Kudzoreredza

A BATA FreeRelease | eTurboNews | eTN
rakanyorwa Linda Hohnholz

Golden Biotechnology Corp. kambani yekuTaiwanese biopharmaceutical, yakazivisa kuti Phase 2 COVID-19 kuyedzwa kwemushonga mutsva wemukanwa Antroquinonol (HOCENA®) yawana 100% kupora mhedzisiro yemhedzisiro yayo yekutanga muchipatara nyoro, pakati nepakati kusanganisira ICU varwere vakakomba.

Zvinoenderana nechirongwa ichi, GoldenBiotech ichaendesa gwaro rekupedzisira rekuongorora kiriniki uye magwaro ane hukama neR&D kuUS FDA kuti inyorere mvumo yekushandisa emergency (EUA) yeAntroquinonol (HOCENA®).          

Muyedzo uyu ndeweChikamu chechipiri chakasarudzika, chakapetwa kaviri, chinodzorwa ne placebo kuongorora kuchengetedzeka uye kushanda kweAntroquinonol muvarwere vari muchipatara vane hunyoro kusvika pakati nepakati pneumonia nekuda kweCOVID-2 (Coronavirus SARS-CoV-19 chirwere). Chaizvoizvo, kuyedza kwaisanganisira ICU varwere vakaomarara vanoda rubatsiro rweokisijeni. Kutevera kupedzwa kwese kuongororwa kwekuongorora uye kusangana kwemaitiro ekukodzera, varwere vanozogamuchira 2mg yeAntroquinonol kana placebo kaviri pazuva kwemazuva gumi nemana pamwe chete neStandard of Care (SoC) kurapa maererano nenharaunda SoC marongero. Muyedzo uyu wakapedza kutsvagira varwere zana nemakumi maviri nevaviri muUSA, Peru neArgentina uko mhirizhonga nyowani yatekeshera nemhando dzakasiyana dzeSARS-CoV-100.

Iyo kliniki yekuedza data yakaratidza:

 Zuva 1.Result: Muboka reAntroquinonol, chiyero chekudzorera chaiva 14% pazuva rekushanya kwe14. Uyezve, hapana kufa kana kutadza kufema kwakawanikwa muboka reAntroquinonol pazuva rekushanya kwe97.9 nereshiyo yekudzoreredza ye14%.

 (b)  Nguva yekurara muchipatara [ Nguva Yenguva: mazuva 2]: nguva yekuburitswa kwemurwere.Chigumisiro: Nguva yepakati pekurapwa yaiva mazuva 9.5 muboka reAntroquinonol.(c)  Nguva kusvika pamapoinzi maviri ekuvandudza [Nguva Yenguva: mazuva 28] : Chibodzwa chekuchinja kwekiriniki sekuyerwa ne“WHO COVID-4 Clinical Improvement Ordinal Scale” .Chigumisiro: Nguva yepakati kusvika pa 2 mu“WHO COVID-28 Clinical Improvement Ordinal Scale” yaive mazuva makumi maviri nemapfumbamwe muboka reantroquinonol.(d) Nguva yekusununguka kwehutachiona [Nguva Yemazuva: 19 mazuva]: kuyerwa semazuva ekudzidza kubva pakutanga kwekurapa kusvika kune yekutanga yakaipa SARS-CoV-0 PCR test. Mhedzisiro: Nguva yepakati kune virological clearance yaiva mazuva gumi nemana muboka reAntroquinonol.

Mukuongororwa kwekuchengetedza, iyo data yakaratidza kuti Antroquinonol yakaratidza kushivirira kwakanaka uye mhedzisiro.

ZVOKUBVA MUNYAYA INO:

  • Kutevera kupedzwa kwese kuongororwa kwekuongorora uye kusangana kwemaitiro ekukodzera, varwere vanozogamuchira 100mg yeAntroquinonol kana placebo kaviri pazuva kwemazuva gumi nemana pamwe chete neStandard of Care (SoC) kurapa maererano nenharaunda SoC marongero.
  • Muyedzo uyu ndeweChikamu chechipiri chakasarudzika, chakapetwa kaviri, chinodzorwa ne placebo kuongorora kuchengetedzeka uye kushanda kweAntroquinonol muvarwere vari muchipatara vane hunyoro kusvika pakati nepakati pneumonia nekuda kweCOVID-2 (Coronavirus SARS-CoV-19 chirwere).
  • Uyezve, hapana kufa kana kutadza kufema kwakawanikwa muboka reAntroquinonol pazuva rekushanya kwe28 nereshiyo yekudzoreredza ye100%.

<

Nezvomunyori

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...